Discovery of novel, potent and low-toxicity angiotensin II receptor type 1 (AT1) blockers: Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazoles with a chiral center
Keywords: کم سمیت; Benzimidazole; Antihypertension; Chiral drug; Low-toxicity; Molecular docking;